China Trials 2023
8 - 10 November 2023 | Shanghai, China | JW Marriott Hotel Shanghai at Tomorrow Square
Thank you for speaking with the ICON team at China Trials 2023.
We invite you to explore the resources we have assembled below to demonstrate how we can support you.
Contact us for more information or to arrange a meeting with our experts.
Factsheets:
The dynamics of drug development in China
A land of opportunity with the right partner.
Biotech
Helping biotech meet critical milestones.
ICON Safety Reporting Solution
ICON Central Laboratories
ICON Ophthalmology Services
Capabilities and Expertise.
Decentralised Clinical Trial Solutions
Delivering quality data quicker for faster time to market.
Pharmacovigilance & Patient Safety
Solutions in response to COVID-19.
Whitepapers:
Spotlight on Regulatory reforms in China
Procedural and regulatory know-how for China biotech in the EU
How to navigate European Medicines Agency registration and regulation.
Pharmacovigilance Affiliate Solutions
Why outsourcing pharmacovigilance makes sense at an affiliate level.
Oncology Clinical Development
Mainstreaming Cell & Gene Therapies
Development, manufacturing, regulation and market access.
The RACE for Children Act
How industry can accelerate readiness through collaboration with patient organisations.
Considerations for DTx clinical trials in CNS indications
Exploring the role of DTx in CNS treatment.
FSP for midsize pharma
How all sponsors can benefit from a synchronised outsourcing strategy.
Regulatory considerations for Biotech
Early engagement and regulatory considerations for biotech.
Global Agency Meeting
A collaborative approach to drug development.
Case studies:
Driving high quality in global clinical drug trials
How Chinese based biotech employed FSP solution to deliver improved quality, performance and team management.
Successful adaptation to complex dose escalation within a large master protocol basket design across Immuno-Oncology co-therapies
Leveraging Immuno-Oncology real world data to amend non-small cell lung cancer study design
